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The mRNA encoding the Drosophila Zn-finger transcription factor Nerfin-1, required for CNS axon pathfinding events, is subject to post-
transcriptional silencing. Although nerfin-1mRNA is expressed in many neural precursor cells including all early delaminating CNS neuroblasts, the
encoded Nerfin-1 protein is detected only in the nuclei of neural precursors that divide just once to generate neurons and then only transiently in
nascent neurons. Using a nerfin-1 promoter-controlled reporter transgene, replacement of the nerfin-1 3′ UTR with the viral SV-40 3′ UTR releases
the neuroblast translational block and prolongs reporter protein expression in neurons. Comparative genomics analysis reveals that the nerfin-1
mRNA 3′ UTR contains multiple highly conserved sequence blocks that either harbor and/or overlap 21 predicted binding sites for 18 different
microRNAs. To determine the functional significance of these microRNA-binding sites and less conserved microRNA target sites, we have studied
their ability to block or limit the expression of reporter protein in nerfin-1-expressing cells during embryonic development. Our results indicate that
no single microRNA is sufficient to fully inhibit protein expression but rather multiple microRNAs that target different binding sites are required to
block ectopic protein expression in neural precursor cells and temporally restrict expression in neurons. Taken together, these results suggest that
multiple microRNAs play a cooperative role in the post-transcriptional regulation of nerfin-1mRNA, and the high degree of microRNA-binding site
evolutionary conservation indicates that all members of theDrosophila genus employ a similar strategy to regulate the onset and extinction dynamics
of Nerfin-1 expression.
Published by Elsevier Inc.Keywords: MicroRNAs; Post-transcriptional regulation; Nervous system developmentIntroduction
The Drosophila nerfin-1 gene encodes a transcription factor
that is essential for the wild-type expression pattern of a subset
of axon guidance genes in nascent neurons (Kuzin et al., 2005).
The Nerfin-1 protein belongs to a highly conserved subfamily
of transcriptional regulators that are identified by their unique
set of tandem Zn-fingers called the EIN-domain (Stivers et al.,
2000). EIN-domain Zn-finger genes are present in all
metazoans, including nematodes (Desai et al., 1988) and man
(Goto et al., 1992), and expression studies reveal that, as in
Drosophila, they are expressed in the developing nervous
system (Wu et al., 2001; Breslin et al., 2003). Although nerfin-1⁎ Corresponding authors. Fax: +1 301 402 0245.
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doi:10.1016/j.ydbio.2007.07.012mRNA expression is detected in most, if not all, CNS
neuroblasts (NBs), ganglion mother cells (GMCs) and nascent
neurons, the nuclear located Nerfin-1 protein is restricted to
those neural precursor cells that divide only once to yield
neurons and then found just transiently in the new born neurons
(Kuzin et al., 2005). For example, during early CNS lineage
development nerfin-1 mRNA expression is detected in many
neural precursor cells including most NBs and GMCs, however,
significant levels of Nerfin-1 protein are detected only in MP
NBs and in GMCs that undergo a single-cell division to
generate neurons (Fig. 1; also see Kuzin et al., 2005). The
observation that prolonged ectopic expression of Nerfin-1
protein in neurons is lethal also suggests that temporal
regulation of Nerfin-1 expression is critical (Kuzin et al., 2005).
Recent in vitro studies in cultured Drosophila S2 cells
indicate that the block or inhibition of nerfin-1 mRNA
translation in the developing nervous system may be the result
Fig. 1. nerfin-1 mRNA and protein expression during embryonic stages 10, 13
and 14. Whole-mount in situ hybridizations and immunostains reveal nerfin-1
mRNA (panels A, C and E) and Nerfin-1 protein (panels B, D and F)
distributions in stage 10 (panels A and B) and stage 13 (panels C and D)
embryos. (A and B) During embryonic stage 10, most if not all ventral cord
neuroblasts express nerfin-1 mRNA albeit at varying levels. However, during
this developmental period, only a single neuroblast per hemisegment, the MP2,
expresses detectable levels of Nerfin-1 protein. Shown are ventral views of the
4th thoracic and 1–3 abdominal segments (arrowheads indicate the ventral
midline, anterior is up). (A, inset) Higher magnification reveals that the nerfin-1
mRNA is not evenly distributed in neuroblasts. The MP2 neuroblasts (asterisk)
have higher in situ hybridization signals while flanking neuroblasts contain less
in situ staining that is asymmetrically located in a patchy subcellular
distribution. (C and D) During stage 13, most if not all nerfin-1 mRNA
expressing secondary PNS precursor cells and nascent neurons are also
immunopositive for Nerfin-1 protein. Shown are flattened left side embryo
fillets that reveal nerfin-1 mRNA (C) and protein (D) distribution within the
PNS and the left half of the ventral cord (on the right, anterior up). (E and F) By
late stage 14, there is a significant reduction of both the mRNA and protein
steady state levels of nerfin-1 in the developing nervous system.
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Rehwinkel et al., 2006). nerfin-1 is targeted by miR-9b, but not
miR-9a in cultured cells, and repression was relieved in Drosha-
and AGO1-depleted cells, indicating that nerfin-1 is a genuine
target of the miRNA pathway (Rehwinkel et al., 2006). miRNA
genes encode small regulatory RNAs (21–22 nt) that are
incorporated into silencing complexes that cleave and/or inhibit
the translation of specific target mRNAs. Nucleotide base-
pairing between miRNAs and target sites found in the 3′UTR of
mRNA triggers the translational inhibition and/or cleavage of
the mRNA (reviewed by Lai et al., 2003; Bartel et al., 2004;
Filipowicz, 2005; Carthew, 2006). mRNA–miRNA base-
pairing to as few as eight bases is sufficient for binding and
silencing (Brennecke et al., 2005; Ma et al., 2005). In Droso-
phila, there are∼100 miRNA genes, and bioinformatics screens
have identified numerous potential mRNA targets for miRNAs
(Enright et al., 2003). Previous studies have demonstrated that
Bearded gene family members (Lai et al., 2005), the Delta gene
(Kwon et al., 2005), and apoptosis pathway genes (Leaman et
al., 2005) all undergo miRNA-mediated post-transcriptional
regulation. miRNAs have also been shown to regulate neural
development in Caenorhabditis elegans (Johnston et al., 2005),
in Drosophila (Li et al., 2006) and in mammals (Conaco et al.,
2006).
Different miRNA target prediction methods, that utilize
overlapping sets of binding site selection criteria, have all
identified multiple miRNA binding sites within the nerfin-1
1.6 kb 3′ UTR, many of which are conserved in multiple Dro-
sophila species (see below; discussed in Stark et al., 2005,
Supplemental data). To determine the in vivo significance of the
predicted miRNA target sites within the highly conserved 3′
UTR sequences, we employed nerfin-1 promoter regulated
transgenes to test their ability to inhibit reporter protein
expression in neural precursor cells and nascent neurons. Here,
we show that multiple 3′ UTR binding sites for different
miRNAs, but not single miRNA binding sites, are required for
nerfin-1 post-transcriptional regulation in both the developing
CNS and PNS. These studies reveal that in the developing CNS
miRNA-mediated post-transcriptional regulation primarily lim-
its the spatial distribution of Nerfin-1 while in the developing
PNS it plays an important role in restricting its temporal ex-
pression in nascent neurons.
Materials and methods
Generation of nerfin-1 miRNA-binding site reporter constructs
To test if the differently conserved nerfin-1miRNA-binding sites play a role
in in vivo post-transcriptional regulation, a nerfin-1 reporter transgene was
prepared by modifying a nerfin-1 rescue construct (Kuzin et al., 2005) that
contained both upstream and downstream transcriptional cis-regulatory regions.
Assembled using standard molecular biology methods, the initial pCaSpeR-3-
based transgene, P[nerfin-1.GFP-NLS.SV-40], contains the following three
DNA fragments in 5′ to 3′ order: (1) 5947 bp of nerfin-1 genomic DNA that
includes 5762 bp of upstream genomic transcriptional regulatory sequences, the
nerfin-1 transcription start site and its 5′ UTR; (2) 1104 bp DNA fragment from
the pH-Stinger plasmid (Barolo et al., 2004) that contains an ORF encoding a
nuclear targeted green fluorescent protein linked to the SV-40 3′ UTR; and (3)
2124 bp of 3′ flanking nerfin-1 genomic DNA that contains additional
37A. Kuzin et al. / Developmental Biology 310 (2007) 35–43transcriptional regulatory sequences (details of the cloning steps are available
upon request). To generate the iA (1668 bp), iB (354 bp), iF (514 bp), iH
(852 bp), iJ (138 bp) and iL (266 bp) nerfin-1 3′ UTR reporter constructs (see
Fig. 2B), PCR-amplified fragments were inserted into a unique Not-I site within
the P[nerfin-1.GFP-NLS.SV-40] vector located in the SV-40 3′UTR, 14 bp 3′ ofFig. 2. The nerfin-1 3′ UTR contains multiple highly conserved miRNA-binding sites
the following Drosophila species were used to generate the EvoPrint: D. melanog
D. pseudoobscura, D. willistoni, D. mojavensis and D. grimshawi. Conserved seq
uppercase black letters and non- or less-conserved sequences are indicated as low
identified previously by Stark et al. (2005) and Enright et al. (2003), are underlined.
gaps in their DNAs. (B) A linear map of the nerfin-1 3′ UTR miRNA-binding sites
miRNA responsive activity within the P[nerfin-1.GFP-NLS.SV-40] transgenic reporthe GFP ORF translation stop codon. The following PCR primers were used to
amplify the different 3′ UTR regions:
iA: 5′-CCATGGCCCACTGAAATCGAGTGAG-3′ and 5′-CCCTGACAA-
CCCAAAGAGAACCCAACAAG-3′. (A) Shown is an EvoPrint of the 1.6 kb nerfin-1 3′ UTR. DNA sequences from
aster (reference sequence), D. sechellia, D. yakuba, D. erecta, D. ananassae,
uence blocks, present in all, or in all but one of the species, are indicated by
ercase gray letters. Predicted RNA-binding sites for 18 different miRNAs, as
Note, D. simulans and D. virilis were not used in the analysis due to sequencing
aligned with the different DNA fragments (iA through iL) that were tested for
ter (see Materials and methods for reporter construct details).
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GGTACACAAGAGACACTC-3′
iF: 5′-GAGTGTCTCTTGTGTACCACGAAGGC-3′ and 5′-CCTGAA-
TATGACTAAAGCTGTATCCG-3′
iH: 5′-CGGATACAGCTTTAGTCATATTCAGG-3′ and 5′-CCCTGA-
CAACCCAAAGAGAACCCAACAAG-3′
iJ: 5′-CTCAGTTTAGTTTAGTTAGTT-3′ and 5′-GCTTTAAGTACA-
CAACCGCC-3′
iL: 5′-GTGTAAATTGGTTGTAACCGC-3′ and 5′-GGTCTTCAA-
GAGTTTGTTTTTG-3′.
For the shorter inserts iC (35 bp), iD (28 bp), iE (33 bp), iG (30 bp), iI
(32 bp) and iK (29 bp) and the following doubled-stranded synthetic oligos were







Drosophila P-element transformants and stocks
Germ-line transformants were generated using standard techniques based on
the methodology described in Rubin and Spradling (1982). Constructs were
injected into Df(1)w67c,y, y w, or w118 strains using delta 2–3 helper DNA
(Rubin and Spradling, 1982). Standard animal husbandry procedures were used
in the care and handling of Drosophila stocks (Ashburner, 1989).
Immunohistochemistry and mRNA localization
Embryo fixation and whole-mount immunostaining of 8- and 16-h embryo
collections were carried out according to the procedures described in Patel
(1994). Rabbit anti-GFP was obtained from Invitrogen and used at a 1:2000
dilution. Nerfin-1 immunostains were performed according to the procedure
described in Kuzin et al. (2005). Vectastain ABC second antibody avidin/biotin
HRP visualization reagents were used according to the manufacturer's protocol
(Vector Labs). For in situ hybridization, a nerfin-1 single-strand riboprobe was
prepared from a full-length cDNA (Stivers et al., 2000) as previously described
(Kopczynski et al., 1998), with the exception that the riboprobe was prepared
from PCR-amplified cDNAwith a labeling mix containing Fluorescein-12-UTP
(Roche) and visualized using anti-FITC Fab fragments coupled to alkaline
phosphatase. To detect P[nerfin-1.GFP-NLS.SV-40] transgene mRNA expres-
sion, a GFP single-strand riboprobe was prepared from the PCR-amplified
GFP-NLS ORF of pH-Stinger vector (Barolo et al., 2004). Detailed protocols
for the immunostains and in situ hybridization are available upon request.
Embryos and dissected fillets were viewed in 70% glycerol with 30%
phosphate-buffered saline (PBS) and photographed using a Nikon Optiphot
microscope equipped with DIC/Nomarski optics. Embryo developmental
staging was determined by morphological criteria (Campos-Ortega and
Hartenstein, 1985).Results and discussion
Nerfin-1 protein expression is blocked in most CNS neuroblasts
During embryonic stage 10, nerfin-1mRNA is detected in all
early delaminating CNS NBs albeit at differing levels; and
within many of the NBs the message appears to be asymme-
trically distributed (Fig. 1A and Stivers et al., 2000). Although
nerfin-1 mRNA expression is pan-neural during this early
stage in CNS development, immunostains using different
Nerfin-1-specific polyclonal antibodies detect significant levelsof Nerfin-1 protein only in the ventral cord MP2 NBs (Fig. 1B
and Kuzin et al., 2005). The punctate/irregular distribution of the
nerfin-1 mRNA in NBs lacking detectable levels of Nerfin-1
protein (Fig. 1A, insert) is reminiscent of that observed for
mRNAs targeted for miRNA-mediated cleavage in mammals
(for example, see Liu et al., 2005, and references therein),
suggesting that nerfin-1 message in many of the NBs may
likewise be targeted for degradation.
Although the dynamics of nerfin-1 mRNA and protein
expression differ considerably during the early stages of nervous
system development, by stage 13 the pattern of Nerfin-1 ex-
pression closely matches that of its mRNA and close inspection
of nerfin-1 message distribution in the Nerfin-1 protein-
expressing cells revealed an even cytoplasmic distribution
(Figs. 1C, D and data not shown). Expression of both the
message and protein in the new born CNS and PNS neurons is
short-lived; levels of both rapidly decline such that by late stage
14, both message and protein levels are significantly lower
throughout the nervous system (Figs. 1E and F; also see Stivers
et al., 2000; Kuzin et al., 2005).
Predicted miRNA-binding sites overlap highly conserved
nerfin-1 3′ UTR sequences
miRNA target prediction programs have identified multiple
putative miRNA binding sites within the nerfin-1 1622 bp 3′
UTR and many of these sites are conserved in other nerfin-1
Drosophila orthologues (Stark et al., 2003; Grun et al., 2005;
reviewed in Stark et al., 2005). For example, a Drosophila
EvoPrint (Odenwald et al., 2005) of the nerfin-1 locus (using
Drosophila melanogaster as the reference sequence and Dro-
sophila sechellia, Drosophila yakuba, Drosophila erecta, Dro-
sophila ananassae, Drosophila persimilis, Drosophila
pseudoobscura, Drosophila willistoni, Drosophila mojavensis
and Drosophila grimshawi as test sequences) revealed con-
served sequence blocks within the 3′ UTR that contain or
overlap 21 predicted miRNA binding sites for 18 different
miRNAs (Fig. 2A). The conserved sequences (shown in upper
case black) are present in all, or all but one, species used in the
analysis and represent over 100 million years of collective
evolutionary divergence. The partial and/or interrupted con-
servation within the predicted miRNA binding sites may reflect
the fact that initial base-pairing of an miRNA and its mRNA
target sequence requires only eight bases to initiate translational
regulation (Lewis et al., 2003, 2005; Lai et al., 2005). EvoPrint
analysis of the nerfin-1 3′ UTR also identified additional
conserved sequence blocks that do not contain or overlap
predicted miRNA binding sites and their role(s) in gene function
are currently unknown (Fig. 2A). In vivo cis-regulatory analysis
of the nerfin-1 3′ UTR failed to detect any transcriptional
enhancer activity (unpublished results; Kuzin et al.). In addition
to the conserved miRNA target sites, less conserved predicted
binding sites have been identified within the 3′UTR (Stark et al.,
2003; Grun et al., 2005; reviewed in Stark et al., 2005). For
example, the central miR-279/miR-286 and miR-279 target sites
are present in the species that are evolutionarily close to D.
melanogaster but not conserved in the more distant D.
39A. Kuzin et al. / Developmental Biology 310 (2007) 35–43persimilis, D. pseudoobscura, D. willistoni, D. mojavensis and
D. grimshawi species (Fig. 2A).
The conservation of nerfin-1 miRNA sites suggests that
miRNA-mediated post-transcriptional regulation of nerfin-1
occurs in all members of this genus. MicroRNAs most likely
regulate other EIN-domain-containing zinc finger genes. For
example, multiple miRNA binding sites have also been detected
in the vertebrate IA-1 3′ UTR (Griffiths-Jones et al., 2006), and
EvoPrint analysis reveals that one of the sites within the human
IA-1 gene is highly conserved (data not shown).
Multiple miRNA binding sites are required to block Nerfin-1
expression in CNS neuroblasts
To determine if the conserved nerfin-1 3′ UTR sequences are
required for the embryonic NB post-transcriptional regulation, a
series of reporter transgene constructs were generated that tested
the silencing activity of different regions of its 3′ UTR. The
starting construct was prepared by replacing the nerfin-1 ORF
and 3′ UTR in an 11-kb nerfin-1 genomic rescue construct
(Kuzin et al., 2005) with a sequence that contains the ORF for a
nuclear-targeted green fluorescent protein (GFP-NLS) linked to
the viral SV-40 3′ trailer that lacks any predicted miRNA
binding sites. As expected, transformants that contain the P
[nerfin-1.GFP-NLS.SV-40] construct expressed GFP in all early
delaminating CNS NBs and no translational block of GFP
expression was detected when compared to nerfin-1 mRNA
expression (Fig. 3A and data not shown). The full-length or
different sub-regions of the nerfin-1 3′ UTR containing the
conserved sequence blocks (Fig. 2B) were then inserted into a
unique restriction site within the vector's SV-40 3′ UTR.
Embryo GFP-immunostains were performed on multiple
independent transformant lines for each construct (results
summarized in Table 1). As controls, multiple independent
transformant lines that contain the nerfin-1 3′UTR sequences in
the opposite orientation were also generated for each construct
and embryo GFP-immunostains revealed that, in all cases, the
translational block in GFP expression was orientation-depen-
dent (data not shown).
Insertion of the full-length 3′ UTR into the P[nerfin-1.GFP-
NLS.SV-40] reporter (construct iA) recapitulated the silencing
of nerfin-1 mRNA translation (Fig. 3B). Similar to the endo-
genous Nerfin-1 protein expression during embryonic stages 10
and 11, significant levels of GFP expression in the ventral cord
were observed only in the MP2 NBs. However, reporter
transgenes that contained sub-regions of the 3′ UTR gave only
partial or no block in NB GFP expression (Fig. 3 and
summarized in Table 1). For example, although the iB and iH
constructs, consisting respectively of the conserved 5′ and 3′
multiple miRNA binding site sub-regions, significantly reduced
GFP expression in stage 11 NBs, both of these sub-regions only
partially blocked expression during stage 10 (Figs. 3C and G).
Further sub-division of the 5′ conserved miRNA binding site
cluster (constructs iC, iD and iE) revealed that the overlapping
miR-9A, miR-9B and miR-9C binding sites and the miR-279/
mir-286 both contributed to the partial inhibition observed with
the iB construct, but the conserved BantammiRNA-binding sitedid not (Figs. 3D–F). It is worth noting that the 5′ predictedmiR-
279/mir-286 target site within our nerfin-1 rescue construct
(Kuzin et al., 2005) contains the sequence TCTAGTCA that
agrees with the predicted miR-279/mir-286 binding site. This
sequence differs in the second to last base from that of the
D. melanogaster genomic sequence (FlyBaseBLAST), in which
there is a T in place of C. cDNA sequence analysis of all ESTs in
the database reveals a C instead of a T at this position.
Given that only the full-length insert recapitulates the
silencing of endogenous expression in the CNS, it is concluded
the miRNAs act in a cooperative fashion to regulate the onset of
Nerfin-1 protein expression. The block in translation by sub-
regions of the 3′UTRwasmore effective at stage 11 than at stage
10; this could reflect time of onset of miRNA expression or the
possibility that the level of mRNA expression is too high for a
complete block at the earlier stage. Previous studies have shown
that ectopic expression of nerfin-1 outside the wild-type
temporal/spatial boundaries during CNS development results
in axon guidance defects (Kuzin et al., 2005). The requirement
for multiple miRNA binding sites may reflect the need for tight
spatial control of Nerfin-1 expression.
Dissection of the sub-regions reveals that the miR-9A, miR-
9B and miR-9C combined site, as well as the miR-279/mir-286
site, contribute to silencing, but the Bantam site did not show an
effect. The conservation of the Bantam site suggests that it is
functionally important, but no effect on embryonic CNS
expression of nerfin-1 was observed. Consistent with this, no
effect on Nerfin-1 protein expression was detected in bantam
minus embryos (data not shown). Bantam has been shown to
have developmental roles in post-embryonic development
(Brennecke et al., 2003). Analysis of the 3′ sub-region sites
(constructs iG, iI, iJ, iK and iL) indicates that in the CNS, the
combined miR-279/miR-286 site (construct iI) exhibits partial
silencing, with no effect observed for the other miRNA binding
sites. Interestingly, the less conserved centrally located miR-
279/miR-286 and miR-279 sites, contained in construct iF, did
not promote silencing (data not shown). These two sites share
less homology to the miR-279 and miR-286 binding sites than
the other conserved miR-279/mir-286 target sites (http://www.
microrna.org/drosophila/targetsv2.html). Construct iG, which
contains the overlapping miR-92A, miR-92B, and miR-310–313
sites revealed no detectable miRNA silencing. In addition,
construct iK that contains a predicted miR-5 binding site did not
affect the reporter mRNA translation in the embryonic CNS and
PNS (data not shown). The other sites in the 3′ sub-region
exhibited an effect in PNS silencing (see below), suggesting
spatial specificity for microRNA effects on nerfin-1 expression.
miRNA-mediated post-transcriptional regulation limits the
temporal expression of Nerfin-1 in PNS neurons
During embryonic PNS development, nerfin-1 mRNA and
protein are transiently expressed in secondary precursor cells
that divide once to generate neurons, and then both its transcript
and encoded protein are only transiently detected in nascent
neurons (Figs. 1C and D; Stivers et al., 2000; Kuzin et al., 2005).
Unlike the post-transcriptional regulation observed in the
40 A. Kuzin et al. / Developmental Biology 310 (2007) 35–43developing CNS, when the full-length nerfin-1 3′ UTR was
included in the reporter transgene the onset of GFP expression
was not blocked in precursor cells but the duration of GFP
expression in the nascent neuron was significantly reduced
(Fig. 4B and data not shown). The rapid extinction of detectable
GFP expression mirrored that of the endogenous Nerfin-1
transient expression; the short-lived expression was observed
throughout the PNS in the ventral, lateral and dorsal neuronssuch that by stage 15 little or no GFP immunostaining was
detected. Similar to the reporter results obtained in the CNS for
the different 3′ UTR sub-regions, no one sub-region or single
miRNA binding site was able to fully limit GFP expression in
older stage 14 and 15 neurons (Figs. 4C–H). However, except
for the predicted Bantam miRNA-binding site that showed no
detectable effect on silencing GFP expression, all of the other 3′
UTR sub-regions exhibited different degrees of silencing. Each
Table 1
Results summary for the different nerfin-1 miRNA-binding site reporter transgenes
Constructs Transformant
lines a
CNS PNS (Stage 15) Figure(s)
Stage 10 Stage 11 Dorsal Lateral Ventral′ Ventral
Vector 5 − b − − − − − 3A, 4A
+ iA 5 ++++ ++++ ++++ ++++ ++++ ++++ 3B, 4B
+ iB 5 ++ +++ ++ ++ ++ ++ 3C, 4C
+ iC 5 ++ ++ − − − − 3D
+ iD 6 ++ ++ +++ ++ ++ ++ 3E, 4D
+ iE 7 − − − − − − 3F
+ iF 6 − − − − − − Not shown
+ iG 3 − − − − − − Not shown
+ iH 4 +++ +++ ++++ ++++ ++++ +++ 3G, 4E
+ iI 7 + ++ + + ++ ++ 3H, 4F
+ iJ 6 − − ++ + ++ ++ 4G
+ iK 3 − − − − − − Not shown
+ iL 3 − − ++ + ++ ++ 4H
a Number of independent transformant lines tested.
b Ranking of reduction in GFP expression (−, no effect; ++++, full block similar to Nerfin-1 protein expression pattern).
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different cells of the PNS (Fig. 4), suggesting an involvement
of miRNAs in cell-type regulation of Nerfin-1 expression. For
example, construct iB, containing the 5′ end of the 3′ UTR,
exhibited a higher levels of silencing in individual cells of the
dorsal (d) and lateral (l) clusters (Fig. 4C); construct iH,
containing the 3′ end of the 3′ UTR, exhibited a higher level of
silencing in the chordotonal neurons in the lateral cluster than in
other cells of the lateral and ventral clusters; construct iJ,
containing a subset of sites in the 3′ UTR, exhibited a higher
level of silencing in a subset of cells in the dorsal and lateral
clusters than in other cells of the same clusters (Fig. 4G).
Taken together, the data suggest that the miRNA binding sites
in the 3′ UTR are required to restrict the onset (CNS) and
extinction (PNS) dynamics of Nerfin-1 protein expression. The
limited expression of Nerfin-1 protein may be the result of
translational inhibition and/or enhanced miRNA-mediated
degradation of the nerfin-1 mRNA. To determine whether
mRNA expression dynamics were different for different
constructs and thus were affected by the presence of different
combinations of nerfin-1 miRNA binding sites, we compared
the mRNA expression dynamics of the nerfin-1.GFP-NLS.SV-
40 transgene to mRNA expression dynamics of this transgene
containing the various nerfin-1 3′ UTR fragments. Our in situ
hybridization mRNA study of embryos containing theseFig. 3. The nerfin-1 3′UTR contains multiple sequences that block protein expression
11 (right side of each panel) embryos that were immunostained in whole-mount for G
Embryos were collected from transformant lines that harbor different nerfin-1 miRN
nerfin-1 3′ UTR inserts). (A) Vector alone (no nerfin-1 3′ UTR sequences); No b
nerfin-1 mRNA expression. (B) Vector with the iA fragment (complete nerfin-1 3′
only neuroblast to express significant levels of GFP during this phase of development
miR-279/miR-286 and bantam miRNA-binding sites); GFP expression is partially bl
observed in transformants containing the full-length nerfin-1 3′ UTR iA construct. (D
sites); GFP expression is only partially blocked during stages 10 and 11. (E) Vector plu
only partially blocked during stages 10 and 11. (F) Vector plus iE (contains the ban
embryonic development. GFP immunostaining was indistinguishable to that observe
92B, miR-310–313, miR-279/286, miR-34, miR-315, miR-305, miR-307, miR-5 and m
not as complete as with the full-length 3′ UTR iA construct. (H) Vector plus iI (contain
GFP expression is detected during both developmental stages.different nerfin-1 3′ UTR transgene constructs revealed that
none of the nerfin-1 miRNA binding site constructs exhibited a
marked alteration of the PNS or CNS expression dynamics of the
reporter transgene during embryonic development (Fig. 5 and
data not shown). However, because our in situ hybridizations
only reveal relative steady state mRNA levels, we cannot
definitively rule out the possibility that the miRNAs may be
promoting nerfin-1 mRNA degradation.
Whereas the overlapping miR-9A, miR-9B, and miR-9C
target sites showed partial silencing of nerfin-1 expression in the
CNS, no effect was observed in the PNS. Interestingly,
mutational analysis of amiR-9amutant reveals that it is required
for embryonic PNS development, and it has been shown to
silence expression of senseless mRNA (Li et al., 2006).
However, our studies show that miR-9A is unlikely to be a
dominant regulator of embryonic Nerfin-1 protein expression;
analysis with a number of cell fate markers reveal that nerfin-1
mutation is not likely to effect embryonic PNS cell fate (Kuzin et
al., 2005) and staining miR-9a mutants (Li et al., 2006) with
antibody to Nerfin-1 reveals no alteration in the number or
positions of Nerfin-1 positive cells (data not show). In contrast,
the miR-305 and miR-13B sites within construct iL partially
reduced reporter expression in the PNS but not in the CNS, and
the combined miR-34/315/305, miR-307 sites also exhibited
partial silencing in the PNS but not in the CNS. This observationin CNS neuroblasts. Shown are embryonic stages 10 (left side of each panel) and
FP expression and then filleted to reveal most of the ventral cord (anterior is up).
A-binding site reporter transgenes (see Fig. 2 for the locations of the different
lock in GFP expression was observed. GFP expression matches endogenous
UTR); GFP expression mirrors that of the endogenous Nerfin-1 protein. The
is the MP2 neuroblast. (C) Vector plus iB (contains themiR-9A,miR-9B,miR-9C,
ocked at stage 10, however, by stage 11 GFP expression pattern is close to that
) Vector plus iC (contains the overlapping miR-9A, miR-9B and miR-9C binding
s iD (contains just themiR-279/mir-286 binding sites); like iC, GFP expression is
tam binding site); no block in GFP expression was detected at any time during
d in embryos with the vector alone. (G) Vector plus iH (contains miR-92A, miR-
iR-13B sites); GFP expression in neuroblasts other than the MP2 is blocked but
s the overlappingmiR-279 andmiR-286 binding sites); only a slight reduction in
42 A. Kuzin et al. / Developmental Biology 310 (2007) 35–43suggests that part of the reason for the complexity of miRNA
binding sites in the nerfin-1 3′ UTR could be due to tissue
specificity of miRNA expression.
Summary
We have examined the ability of the predicted miRNA
binding sites within the Drosophila nerfin-1 3′ UTR to silence
mRNA translation in vivo. The principle finding of this study is
that multiple miRNAs act cooperatively to regulate the spatialFig. 5. nerfin-1 3′ UTR miRNA-binding sites do not significantly alter the
steady state levels of the reporter transgene mRNA. Transgene mRNA
expression was detected using a GFP-specific riboprobe. Shown are late stage
13 embryo fillets (left side with anterior up). (A) Vector alone. (B) Vector with
the iA fragment (the complete nerfin-1 3′ UTR).and temporal expression of Nerfin-1 in the developing
embryonic nervous system. Indeed, no single miRNA-binding
site is sufficient to recapitulate the endogenous post-transcrip-
tional regulation in either the embryonic CNS or PNS. In the
CNS, mRNA binding sites for multiple miRNAs are required to
regulate the spatial expression of Nerfin-1 by silencing
expression in all but the MP NBs. In the developing PNS,
these studies indicate that miRNA-mediated regulation does not
restrict the onset of Nerfin-1 expression but rather it helps acce-
lerate the rate of disappearance of Nerfin-1 in nascent neurons.
Whereas the whole 3′ UTR was required for wild-type
expression of nerfin-1, three individual sites had a partial effect
of silencing in the CNS and four individual sites had only a
partial effect in silencing in the PNS. The incomplete silencing in
the CNS was stronger at a later stage of development than at an
earlier stage, pointing to temporal effects of individual miRNAs.Fig. 4. nerfin-1 3′ UTR miRNA-binding sites reduce reporter protein expression
in nascent PNS neurons. Shown are lateral, flattened views of abdominal 1–4
segments (dorsal up) from late stage 14/early stage 15 whole-mount GFP
immunostained embryos from nerfin-1 miRNA-binding site reporter transfor-
mant lines (see Fig. 2 for a linear map of the tested sequences). (A) Vector alone;
most, if not all, PNS neurons express GFP (brackets v, v′, l and d indicate the
two ventral, lateral and dorsal neuronal cell clusters as described by Brewster
and Bodmer, 1995). (B) Vector plus iA (complete nerfin-1 3′ UTR); low level of
GFP immunostaining through out the PNS matches that of Nerfin-1
immunostains at this stage. (C) Vector with iB (contains the miR-9A, miR-9B,
miR-9C, miR-279/286 and bantam miRNA-binding sites); only partial reduction
of GFP expression in a subset of neurons in all clusters with the most significant
reduction observed in the dorsal cluster. (D) Vector plus iD; similar to iB partial
reduction in GFP expression was observed when just the miR-279/286 binding
sites was included in the reporter vector. (E) Vector plus iH (3′ half of the nerfin-
1 3′ UTR containing the miR-92A, miR-92B, miR-310–313, miR-279/286, miR-
34, miR-315, miR-305, miR-307, miR-5 and miR-13B sites); reduction in GFP
expression in the d and v′ clusters is similar to that observed with the full-length
iA construct but the reduction in immunostaining was less than that observed
with iA in the v and l PNS cell clusters. (F) Vector with iI (contains the
overlapping miR-279 and miR-286 binding sites); a partial reduction in GFP
expression was observed in all clusters. (G) Vector plus iJ (contains overlapping
miR-34/miR-315/miR-305 binding sites and the miR-307 binding site); partial
reduction in GFP expression was detected in subsets of d and v′ cluster neurons.
(H) Vector plus iL (contains the miR-305/miR-13B miRNA-binding site); partial
reduction in GFP expression was observed in all PNS clusters.
43A. Kuzin et al. / Developmental Biology 310 (2007) 35–43In two instances, partial silencing of nerfin-1 expression is
accomplished by different sites in the CNS and PNS pointing to a
potential tissue specificity of miRNA effects. miR-9A, miR-9B
and miR-9C showed an effect in the CNS but not in the PNS,
and, in contrast, the combined miR-34/315/305, miR-307 sites
(construct iJ) exhibited partial silencing in the PNS but not in the
CNS. The same differential effect was observed for combined
miR-305 and miR-13B binding sites (construct iL). In addition,
in the PNS, partial effects exhibited a degree of cell type
specificity, suggesting that individual miRNAs exhibit cellular
specificity even within a single tissue. Our results suggest that
the high number of conserved miRNA binding sites in the ner-
fin-1 3′RNA are likely to reflect differential temporal and spatial
specificity of miRNA function. Further confirmation of this
awaits in depth studies of the tissue specificity of miRNA
expression.
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